Nature Aging

Nature Aging
Title	Nature Aging
Discipline	Gerontology
Abbreviation	Nat. Aging
Publisher	Springer Nature
Country	United Kingdom
History	2021–present
Frequency	Monthly
Issn	2662-0770

Nature Aging

Nature Aging is a monthly peer-reviewed scientific journal focusing on the biology, medicine, and societal aspects of aging. Launched in 2021, it publishes original research, reviews, and commentaries spanning cellular senescence, geriatric interventions, and population studies. The journal is produced by Springer Nature and interfaces with major research communities and funders worldwide.

Overview

Nature Aging covers topics from molecular mechanisms of aging to clinical trials and demographic research. Articles often bridge work from laboratories associated with Harvard University, Stanford University, University of Oxford, Massachusetts Institute of Technology, University of California, San Francisco, University College London, Max Planck Society, National Institutes of Health, European Research Council, Wellcome Trust, Howard Hughes Medical Institute, Broad Institute, Salk Institute, Karolinska Institutet, MIT Media Lab, Johns Hopkins University, Columbia University, Yale University, University of Cambridge, University of Tokyo, University of Toronto, ETH Zürich, Imperial College London, Cold Spring Harbor Laboratory, Rockefeller University, National Academy of Sciences, American Association for the Advancement of Science, Royal Society, Bill & Melinda Gates Foundation, Chan Zuckerberg Initiative, NIH Clinical Center, Mayo Clinic, Cleveland Clinic, Duke University Medical Center, Karolinska University Hospital, Institut Pasteur, European Molecular Biology Laboratory, Riken, Monash University, Peking University, Tsinghua University, Seoul National University, University of Melbourne, University of Sydney, University of Edinburgh, University of British Columbia, McGill University, University of Copenhagen, Ludwig Maximilian University of Munich and University of São Paulo.

History and Development

The journal was established amid growing interest in translational gerontology, following a period when aging research expanded at institutions such as Harvard Medical School, Stanford School of Medicine, University of California, Berkeley, Princeton University, University of Chicago, Washington University in St. Louis, Vanderbilt University Medical Center, University of Michigan, Wageningen University & Research, University of Groningen and research consortia like the Human Genome Project derivatives and longevity initiatives funded by NIH. Its launch involved editorial leadership drawn from researchers affiliated with Gladstone Institutes, Scripps Research, European Academy of Sciences, Allen Institute for Brain Science, Genome Research Limited, Chinese Academy of Sciences, Indian Council of Medical Research and policy stakeholders connected to World Health Organization and United Nations expert groups. Early commissions highlighted links between basic science exemplified by work at Max Planck Institute for Biology of Ageing and clinical translation at hospitals such as Mount Sinai Health System and Brigham and Women’s Hospital.

Editorial Scope and Content

The journal prioritizes mechanistic studies, randomized controlled trials, population cohorts, and policy analyses intersecting with aging. Content types include Articles, Reviews, Perspectives, News & Views, and Comment pieces often authored by scientists from National Institute on Aging, Medical Research Council, Agency for Science, Technology and Research, Agence Nationale de la Recherche, Canadian Institutes of Health Research, Japan Society for the Promotion of Science, European Commission research programs, and leaders from research centers like Buck Institute for Research on Aging, Ben-Gurion University, University of California, Los Angeles, University of Texas Southwestern Medical Center, Fred Hutchinson Cancer Research Center, St. Jude Children's Research Hospital, Children's Hospital of Philadelphia, Dana-Farber Cancer Institute, Institut Curie, Pasteur Institute, Barcelona Biomedical Research Park, Center for Genomic Regulation, Institut Clinique de la Souris and The Francis Crick Institute. Themes often reference foundational work from researchers historically linked to Leonard Hayflick, Denham Harman, Aubrey de Grey, Elizabeth Blackburn, Stanley Prusiner, Carol Greider, James Watson, Francis Crick, Santiago Ramón y Cajal, Clive McCay, Rita Levi-Montalcini and laboratories known for techniques such as CRISPR described at Broad Institute and EMBL collaborations.

Publication and Peer Review Process

Manuscripts are submitted through the publisher's workflow used across Springer Nature titles and undergo editorial triage followed by external peer review. Reviewers are drawn from networks including faculty at University of Pennsylvania, University of Illinois Urbana-Champaign, University of Washington, Northwestern University, University of North Carolina at Chapel Hill, University of Minnesota, Rutgers University, University of Zurich, Leiden University, University of Basel, Ghent University, KU Leuven, Heidelberg University, Technical University of Munich, Seoul National University Hospital and specialized panels previously convened by agencies like NIH and ERC. The journal employs editorial policies regarding data availability, replication, and ethical compliance consistent with guidelines from Committee on Publication Ethics, funders such as Wellcome Trust and European Research Council, and institutional review boards at hospitals including Royal Free Hospital, Guy's and St Thomas' NHS Foundation Trust, Charité – Universitätsmedizin Berlin and Royal Marsden Hospital.

Reception and Impact

Since its inception the journal attracted attention from researchers involved with longevity startups, biotech firms, and academic centers including Calico, Unity Biotechnology, ResTORbio, Juvenescence, Life Biosciences, Insilico Medicine, Samumed, Elevian, CohBar, Alkahest, Intervene Immune, and stem cell groups at BlueRock Therapeutics. Coverage and critiques have appeared in outlets and forums tied to Nature Research, The Lancet, Science Magazine, Cell Press, PLOS, BMJ, STAT News, The New York Times science desk, The Washington Post, Financial Times science section and academic commentary hosted by National Academy of Medicine symposia, Gordon Research Conferences, Cold Spring Harbor Laboratory Meetings, Keystone Symposia and World Economic Forum panels. The journal's influence is reflected in citations within reports by World Health Organization, policy briefs prepared for European Commission, and strategic documents from funders including Bill & Melinda Gates Foundation and Chan Zuckerberg Initiative.

Indexing and Accessibilities

The journal is indexed in major bibliographic services and citation databases maintained by organizations such as Clarivate Analytics, Scopus, PubMed Central, MEDLINE, CrossRef, Directory of Open Access Journals collaborations, and library consortia including HathiTrust Digital Library and Research4Life. Access models align with Springer Nature licensing used by academic consortia at The Russell Group, Association of American Universities, CARL, CRKN, Jisc and institutional subscriptions at universities like University of Edinburgh, University of Melbourne and National University of Singapore, while individual open-access options mirror policies of funders including Wellcome Trust and European Research Council.

Category:Academic journals